ArticleEJNMMI radiopharmacy and chemistry2026

Assessment of PET drug adverse events in the U.S. since the implementation of 21 CFR part 212.

Marianna Dakanali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.